PEAK6 Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-14,459
Closed -$223K – 4504
2023
Q4
$234K Buy
+14,459
New +$237K ﹤0.01% 3137
2022
Q1
– Sell
-856
Closed -$29K – 5721
2021
Q4
$29K Sell
856
-16,212
-95% -$635K ﹤0.01% 4743
2021
Q3
$823K Sell
17,068
-8,782
-34% -$407K ﹤0.01% 2800
2021
Q2
$1.17M Buy
+25,850
New +$1.15M ﹤0.01% 2411
2020
Q3
– Sell
-10,262
Closed -$381K – 4709
2020
Q2
$318K Sell
10,262
-1,028
-9% -$28.5K ﹤0.01% 3045
2020
Q1
$312K Sell
11,290
-4,483
-28% -$134K ﹤0.01% 2466
2019
Q4
$461K Sell
15,773
-9,520
-38% -$227K ﹤0.01% 2034
2019
Q3
$484K Sell
25,293
-49,203
-66% -$1.15M ﹤0.01% 2300
2019
Q2
$1.63M Buy
74,496
+58,448
+364% +$1.28M 0.01% 1444
2019
Q1
$328K Buy
16,048
+1,616
+11% +$28.1K ﹤0.01% 2647
2018
Q4
$182K Sell
14,432
-31,995
-69% -$477K ﹤0.01% 3092
2018
Q3
$713K Buy
+46,427
New +$642K ﹤0.01% 2280

Other funds holding NEO

PEAK6 Investments's NEO Position: Q1 2024 in Review

PEAK6 Investments sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 14,459 shares — an estimated $223K sold.

PEAK6 Investments first reported a position in NEO in Q3 2018 and held it in 12 quarters. The position peaked at $1.63M in Q2 2019. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • PEAK6 Investments reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 14,459 NeoGenomics shares in Q1 2024, an estimated $223K.
  • PEAK6 Investments first reported a position in NeoGenomics in Q3 2018 and held it in 12 quarters.
  • PEAK6 Investments's NeoGenomics position peaked at $1.63M in Q2 2019.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.